Recent research showed that ErbB2+ breast cancers express higher levels of gene-encoding proteins in the ERAD pathway, potentially as a strategy to cope with ER stress caused by higher ER biosynthetic load from high abundance of ErbB2 and proteins in downstream pathways [14]. Here, ERBB2 is linked to breast carcinoma.